{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:59Z","timestamp":1779926459180,"version":"3.53.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.mayocp.2012.07.016","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T07:15:15Z","timestamp":1351840515000},"page":"1106-1117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Clostridium difficile Infection: New Insights Into Management"],"prefix":"10.1016","volume":"87","author":[{"given":"Sahil","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","article-title":"Antibiotic-associated pseudomembranous colitis due to toxin-producing Clostridia","volume":"298","author":"Bartlett","year":"1978","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/egh.10.48","article-title":"The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings","volume":"4","author":"Khanna","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"23","key":"10.1016\/j.mayocp.2012.07.016_bib3","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality [published correction appears in N Engl J Med. 2006;354(20):2200]","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community-acquired Clostridium difficile infection: a population-based study [published correction appears in Am J Gastroenterol. 2012;107(1):150]","volume":"107","author":"Khanna","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","article-title":"A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use","volume":"26","author":"Muto","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","article-title":"Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity","volume":"171","author":"P\u00e9pin","year":"2004","journal-title":"CMAJ"},{"issue":"18","key":"10.1016\/j.mayocp.2012.07.016_bib7","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile: more difficult than ever [published correction appears in N Engl J Med. 2010;363(16):1585]","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.mayocp.2012.07.016_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archsurg.142.7.624","article-title":"Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States","volume":"142","author":"Ricciardi","year":"2007","journal-title":"Arch Surg"},{"issue":"12","key":"10.1016\/j.mayocp.2012.07.016_bib9","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e31817eef13","article-title":"Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005","volume":"27","author":"Zilberberg","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3201\/eid1406.071447","article-title":"Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005","volume":"14","author":"Zilberberg","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1205.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/511798","article-title":"Recommendations for surveillance of Clostridium difficile-associated disease","volume":"28","author":"McDonald","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2036.2011.04984.x","article-title":"Outcomes in community-acquired Clostridium difficile infection","volume":"35","author":"Khanna","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1542\/peds.2008-0469","article-title":"Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006","volume":"122","author":"Kim","year":"2008","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib16","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/520732","article-title":"Changing epidemiology of Clostridium difficile-associated disease in children","volume":"28","author":"Benson","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jinf.2011.05.016","article-title":"Clostridium difficile in children: colonisation and disease","volume":"63","author":"Enoch","year":"2011","journal-title":"J Infect"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1086\/501990","article-title":"The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children","volume":"23","author":"Langley","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.mayocp.2012.07.016_bib19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/507335","article-title":"Diarrhea etiology in a children's hospital emergency department: a prospective cohort study","volume":"43","author":"Klein","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00006454-198209000-00011","article-title":"Clostridium difficile in a pediatric outpatient population","volume":"1","author":"Boenning","year":"1982","journal-title":"Pediatr Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1017\/S0950268809991646","article-title":"Disease transmission model for community-associated Clostridium difficile infection","volume":"138","author":"Otten","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0016-5085(81)90644-2","article-title":"Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations","volume":"81","author":"Viscidi","year":"1981","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib23","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/JCM.02563-05","article-title":"Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada","volume":"44","author":"MacCannell","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"19","key":"10.1016\/j.mayocp.2012.07.016_bib24","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/JB.00445-10","article-title":"Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production","volume":"192","author":"Merrigan","year":"2010","journal-title":"J Bacteriol"},{"issue":"31","key":"10.1016\/j.mayocp.2012.07.016_bib25","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.31.18942-en","article-title":"Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008","volume":"13","author":"Kuijper","year":"2008","journal-title":"Euro Surveill"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib26","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.2807\/esm.12.06.00714-en","article-title":"Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe","volume":"12","author":"Kuijper","year":"2007","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/649213","article-title":"Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality","volume":"50","author":"Miller","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/510391","article-title":"A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec","volume":"44","author":"Hubert","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib29","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/520984","article-title":"Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027\/toxinotype III in The Netherlands","volume":"45","author":"Goorhuis","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib30","doi-asserted-by":"crossref","first-page":"e1812","DOI":"10.1371\/journal.pone.0001812","article-title":"Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study","volume":"3","author":"Morgan","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/646354","article-title":"Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak","volume":"12","author":"Thibault","year":"1991","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/TA.0b013e31823c5637","article-title":"Evaluating contemporary antibiotics as a risk factor for Clostridium difficile infection in surgical trauma patients","volume":"72","author":"Shah","year":"2012","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib33","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/JCM.01507-10","article-title":"Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition","volume":"49","author":"Rousseau","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1128\/JCM.05176-11","article-title":"Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota","volume":"50","author":"Rea","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.07.016_bib35","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1086\/657319","article-title":"Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease","volume":"202","author":"Manges","year":"2010","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2012.07.016_bib36","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1073\/pnas.1000087107","article-title":"Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation","volume":"108","author":"Dethlefsen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cid\/cir404","volume":"53","author":"Mullane","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib38","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajic.2006.12.006","article-title":"Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities","volume":"35","author":"Dubberke","year":"2007","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/infdis\/143.1.42","article-title":"Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis","volume":"143","author":"Kim","year":"1981","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2012.07.016_bib40","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1086\/591065","article-title":"Strategies to prevent Clostridium difficile infections in acute care hospitals","volume":"29","author":"Dubberke","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib41","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2012.87","article-title":"IBD: Poor outcomes after Clostridium difficile infection in IBD","volume":"9","author":"Khanna","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib43","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1111\/j.1399-0012.2010.01316.x","article-title":"Clostridium difficile-related pancolitis in lung-transplanted patients with cystic fibrosis","volume":"25","author":"Patriarchi","year":"2011","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1086\/501989","article-title":"Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea","volume":"23","author":"Kyne","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.mayocp.2012.07.016_bib45","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinternmed.2010.73","article-title":"Proton pump inhibitors and risk for recurrent Clostridium difficile infection [published correction appears in Arch Intern Med 2010;170(13):1100]","volume":"170","author":"Linsky","year":"2010","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib46","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1086\/508453","article-title":"Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study","volume":"43","author":"Lowe","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2012.07.016_bib47","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1503\/cmaj.060284","article-title":"Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy","volume":"175","author":"Dial","year":"2006","journal-title":"CMAJ"},{"issue":"23","key":"10.1016\/j.mayocp.2012.07.016_bib48","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib49","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1128\/AAC.01506-05","article-title":"In vitro killing of nosocomial pathogens by acid and acidified nitrite","volume":"50","author":"Rao","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/151.2.355","article-title":"Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster","volume":"151","author":"Wilson","year":"1985","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2012.07.016_bib51","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.mayocp.2012.07.016_bib52","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.mayocp.2011.12.021","article-title":"Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study","volume":"87","author":"Khanna","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cgh.2012.01.013","article-title":"Gastric acid suppression and Clostridium difficile infection: is there a causal connection [letter]?","volume":"10","author":"Khanna","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.mayocp.2012.07.016_bib54","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/cid\/cir201","article-title":"Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection","volume":"52","author":"Kufelnicka","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib55","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.anaerobe.2011.01.002","article-title":"Tests for the diagnosis of Clostridium difficile infection: the next generation","volume":"17","author":"Carroll","year":"2011","journal-title":"Anaerobe"},{"key":"10.1016\/j.mayocp.2012.07.016_bib56","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0b013e3182432273","article-title":"An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction","author":"Khanna","year":"2012","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib57","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/JCM.00032-08","article-title":"Comparison of real-time PCR for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection","volume":"46","author":"Sloan","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib58","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1309\/AJCPTP5XKRSNXVIL","article-title":"Laboratory testing for Clostridium difficile infection: light at the end of the tunnel","volume":"136","author":"Peterson","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/658336","article-title":"Comparison of clinical severity score indices for Clostridium difficile infection","volume":"32","author":"Fujitani","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhin.2011.04.017","article-title":"CSI: a severity index for Clostridium difficile infection at the time of admission","volume":"79","author":"Lungulescu","year":"2011","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib62","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jinf.2007.09.015","article-title":"Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system","volume":"55","author":"Belmares","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.mayocp.2012.07.016_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.mayocp.2012.05.025","article-title":"Clostridium difficile infection in patients with chronic kidney disease","author":"Keddis","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"S2","key":"10.1016\/j.mayocp.2012.07.016_bib64","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.14309\/00000434-201110002-00414","article-title":"Clinical predictors of severe complicated Clostridium difficile infection","volume":"106","author":"Shivashankar","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib65","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1086\/662586","article-title":"A targeted strategy to wipe out Clostridium difficile","volume":"32","author":"Orenstein","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib66","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib67","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","article-title":"Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole","volume":"40","author":"Musher","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/13543784.17.4.547","article-title":"OPT-80, a macrocyclic antimicrobial agent for the treatment of Clostridium difficile infections: a review","volume":"17","author":"Gerber","year":"2008","journal-title":"Exp Opin Investig Drugs"},{"issue":"12","key":"10.1016\/j.mayocp.2012.07.016_bib69","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/AAC.48.12.4898-4902.2004","article-title":"In vitro activities of OPT-80 and comparator drugs against intestinal bacteria","volume":"48","author":"Finegold","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib70","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AAC.48.6.2280-2282.2004","article-title":"In vitro activity of OPT-80 against Clostridium difficile","volume":"48","author":"Ackermann","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.mayocp.2012.07.016_bib71","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1128\/AAC.00476-08","article-title":"In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile","volume":"52","author":"Karlowsky","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib72","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinthera.2011.12.003","article-title":"Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections","volume":"34","author":"Lancaster","year":"2012","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib75","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2008.12.038","article-title":"Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection","volume":"136","author":"Hu","year":"2009","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jinf.2009.03.010","article-title":"Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes","volume":"58","author":"Johnson","year":"2009","journal-title":"J Infect"},{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib77","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/cid\/cir632","article-title":"Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection","volume":"53","author":"Gough","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib78","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib79","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2011.11.037","article-title":"Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection","volume":"142","author":"Mattila","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection","volume":"172","author":"Kassam","year":"2012","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.mayocp.2012.07.016_bib81","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cgh.2011.08.014","article-title":"Treating Clostridium difficile infection with fecal microbiota transplantation","volume":"9","author":"Bakken","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib82","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib83","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea [published correction appears in Ann Intern Med. 2005;143(3):239]","volume":"142","author":"DuPont","year":"2005","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib84","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/01.mcg.0000225685.37465.e7","article-title":"Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea","volume":"41","author":"Berman","year":"2007","journal-title":"J Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.mayocp.2012.07.016_bib85","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mayocp.2012.07.016_bib86","doi-asserted-by":"crossref","first-page":"106978","DOI":"10.1155\/2011\/106978","article-title":"Rifaximin is effective for the treatment of Clostridium difficile-associated diarrhea: results of an open-label pilot study","volume":"2011","author":"Rubin","year":"2011","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.mayocp.2012.07.016_bib87","doi-asserted-by":"crossref","first-page":"S-599","DOI":"10.1016\/S0016-5085(12)62296-3","article-title":"The efficacy and safety of rifaximin vs. vancomycin in the treatment of mild to moderate C. difficile infection: a randomized double-blind active comparator trial","volume":"142","author":"Pardi","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.mayocp.2012.07.016_bib88","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1093\/jac\/dkr377","article-title":"A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection","volume":"66","author":"Garey","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib89","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/596552","article-title":"Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study","volume":"48","author":"Musher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib90_1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/506351","article-title":"Nitazoxamide for the treatment of Clostridium difficile colitis [letter]","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib90_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1086\/510083","article-title":"Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis [letter]","volume":"44","author":"Young","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib91","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/141.1.92","article-title":"Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins","volume":"141","author":"Taylor","year":"1980","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib92","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/jhm.542","article-title":"Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature","volume":"5","author":"Abougergi","year":"2010","journal-title":"J Hosp Med"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib93","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.vaccine.2009.10.144","article-title":"Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)","volume":"28","author":"Leav","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib94","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10620-010-1411-2","article-title":"Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review","volume":"56","author":"Abougergi","year":"2011","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib95","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib96","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/IAI.69.2.988-995.2001","article-title":"Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib97","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","article-title":"Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea","volume":"128","author":"Sougioultzis","year":"2005","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.mayocp.2012.07.016_bib98","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1016\/j.vaccine.2012.01.065","article-title":"Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine","volume":"30","author":"Greenberg","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib99","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1503\/cmaj.050350","article-title":"Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review [published correction appears in CMAJ. 2005;173(4):345]","volume":"173","author":"Dendukuri","year":"2005","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib100","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","article-title":"Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa","volume":"67","author":"Castagliuolo","year":"1999","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib101","first-page":"1285","article-title":"Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii","volume":"84","author":"Surawicz","year":"1989","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2012.07.016_bib102","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/318130","article-title":"The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii","volume":"31","author":"Surawicz","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2012.07.016_bib103","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s10350-004-0672-2","article-title":"Outcome after colectomy for Clostridium difficile colitis","volume":"47","author":"Longo","year":"2004","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.mayocp.2012.07.016_bib104","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1177\/000313481107700813","article-title":"Predictors of fatal outcome after colectomy for fulminant Clostridium difficile colitis: a 10-year experience","volume":"77","author":"Markelov","year":"2011","journal-title":"Am Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archsurg.2007.46","article-title":"Predictors of mortality after colectomy for fulminant Clostridium difficile colitis","volume":"143","author":"Byrn","year":"2008","journal-title":"Arch Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/SLA.0b013e31822ade48","article-title":"Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease","volume":"254","author":"Neal","year":"2011","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.mayocp.2012.07.016_bib107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2168.1998.00519.x","article-title":"Timing of surgery for fulminating pseudomembranous colitis","volume":"85","author":"Synnott","year":"1998","journal-title":"Br J Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib108","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjsurg.2007.11.017","article-title":"Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management","volume":"196","author":"Hall","year":"2008","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.mayocp.2012.07.016_bib109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/000313480807400105","article-title":"Early surgical intervention for fulminant pseudomembranous colitis","volume":"74","author":"Ali","year":"2008","journal-title":"Am Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2012.07.016_bib110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjsurg.2008.11.001","article-title":"Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience","volume":"197","author":"Seder","year":"2009","journal-title":"Am J Surg"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612008142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619612008142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T23:33:56Z","timestamp":1675899236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619612008142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":111,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0025619612008142"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.07.016","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clostridium difficile Infection: New Insights Into Management","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2012.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}